GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Insider Ownership

Navana Pharmaceuticals (DHA:NAVANAPHAR) Insider Ownership : 0.00 % (As of May. 24, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Navana Pharmaceuticals's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Navana Pharmaceuticals's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Navana Pharmaceuticals's Float Percentage Of Total Shares Outstanding is N/A.


Navana Pharmaceuticals Insider Ownership Historical Data

The historical data trend for Navana Pharmaceuticals's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Insider Ownership Chart

Navana Pharmaceuticals Annual Data
Trend
Insider Ownership

Navana Pharmaceuticals Semi-Annual Data
Insider Ownership

Navana Pharmaceuticals Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Navana Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines